Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Thrombolytic Therapy

Background and Objectives: Thrombolytic therapy with recombinant tissue-type plasminogen activator (rt-PA) is used to treat acute ischemic stroke. Dabigatran is a reversible thrombin inhibitor approved for stroke prevention in patients with nonvalvular atrial fibrillation. In such cases, thrombolyti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kikule, Ilga, Baborikina, Alise, Haritoncenko, Iveta, Karelis, Guntis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607471/
https://www.ncbi.nlm.nih.gov/pubmed/36295516
http://dx.doi.org/10.3390/medicina58101355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607471/
https://www.ncbi.nlm.nih.gov/pubmed/36295516
http://dx.doi.org/10.3390/medicina58101355

Ejemplares similares